During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

Payments are adjusted based on risk scores representing beneficiaries demographics, location and health needs ... a five-year corporate integrity agreement with the HHS’ Office of Inspector ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

Though they are a part of the Blue Cross Blue Shield Association, affiliates are predominantly owned by Elevance ... corporate secretary. He held leadership positions in the Pennsylvania Governor's ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note ...

Investment analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Elevance Health in a research note ...

Shares of Elevance Health Inc. ELV shed 1.26% to $400.30 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.47% to 6,039.31 ...

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses from patients in its ...

Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large proportion of what it earned was being reinvested back into the business.

INDIANAPOLIS — INDIANAPOLIS — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1.81 per share.